Obdulio Pilt

Obdulio Pil●t● is a seasoned entrepreneur and executive with extensive experience in the biotechnology sector. Currently serving as Managing Partner at Polarity Ventures, Obdulio focuses on developing innovative ideas for niche markets. As Interim CEO and Founder of PCRopsis, Obdulio leads the development of nucleic acid extraction-free technologies for RNA/DNA applications. Obdulio also founded PanGIA Biotech, which is working on a novel non-invasive approach to early cancer diagnosis. Additionally, Obdulio holds various board positions, including at Pathnova Laboratories and the FIU Research Foundation, promoting advancements in diagnostic tests and university research commercialization. Formerly, as Chairman of the Scientific Advisory Board at Conversant Biologics, Obdulio transformed the company into a key player in the biotech sector. Obdulio holds a PhD in Cellular & Molecular Medicine from The Johns Hopkins University and has completed postdoctoral studies at Stanford University.